FDA 501(K) clearance awarded to Cumulus Neuroscience for development of programs for precision CNS medicines 09-May-2023 By Liza Laws Cumulus Neuroscience has been given the clearance by the US Food and Drug Administration (FDA) and the company says this will accelerate treatments for neuropsychiatric and neurodegenerative disorders.